New brain scan study aims to uncover dementia clues in african americans
NCT ID NCT03618186
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses a special PET scan to look at tau protein buildup in the brains of African Americans who are either cognitively normal or have dementia. Researchers hope to learn how these brain changes differ across racial groups. The study involves 240 participants and uses a tracer called flutaucipir to highlight tau deposits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
flutaucipir (tau PET scan tracer)
What this could lead to
If successful, this study could help researchers better understand how tau protein buildup relates to cognitive impairment in African Americans, potentially guiding future diagnostic approaches.
What could go wrong
This is an observational imaging study, not a treatment trial. It is early-stage research focused on gathering data, so it will not directly lead to a new therapy. Results may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Minnesota
Rochester, Minnesota, 55905, United States
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States